Patent Process in India Archives - Page 4 of 26 - GIP Research & Consultancy Services

Patent granted in India to INTEL CORPORATION

August 18, 2021

Patent number 373405 has been granted to INTEL CORPORATION, which is titled CONTROLLED ACCESS TO FUNCTIONALITY OF A WIRELESS DEVICE. The primary independent claim of this patent states an apparatus, having electronic devices including a processor, a memory, and a camera. The patent applicant responded to this objection by stating that the claims have been amended as directed and therefore, the subject matter is directed to an apparatus to perform biometric authentication and not to computer programs per se. This patent falls under the category of Computer Science. Overall, this patent covers the process to verify that a person being authorized by biometric techniques to use a device is a living person and not some form of recording intended to spoof the system.

Patent granted in India to SAMSUNG ELECTRONICS CO. LTD

Patent number 373403 has been granted to SAMSUNG ELECTRONICS CO. LTD which is titled DISPLAY APPARATUS AND METHOD OF CHANGING SCREEN MODE USING THE SAME. The patent applicant responded to this objection by stating that the present invention is of technical nature and provides technical advancement over the cited prior art. Moreover, the amended claims disclose various structural components such as “display unit”, “sensing unit”, “controller”, that work in consonance with each other to achieve the desired technical result. This patent falls under the category of Computer Science. Overall, this patent covers a display apparatus and a method of changing the screen mode using the display apparatus including a display unit, a sensing unit and a controller which changes a screen mode of an object displayed on the display unit according to the bending direction.

Patent granted in India to INDIAN INSTITUTE OF TECHNOLOGY KANPUR

patent number 373162 has been granted to INDIAN INSTITUTE OF TECHNOLOGY KANPURthat is titled NANOPARTICLE-BASED DRUG DELIVERY SYSTEM FOR NICLOSAMIDE AND A COMBINATION THEREOF. The patent applicant responded to this objection by stating that section 3(d) does not apply to the present compounds and that the technical merit of the present invention is further substantiated by embodiments of the present invention. This patent falls under the category of Chemical. Overall, this patent covers a nanoparticle-based drug delivery system for Niclosamide wherein a nanoparticle-based combinatorial drug delivery system comprises a synergistic combination of Niclosamide loaded nanoparticles 15 and Doxorubicin loaded nanoparticles for leads to death of all clinical subtypes of breast cancer cells can be used for treating other cancer types as well covering multiple cancers such as colorectal cancer, prostate cancer, breast cancer, melanoma, gastrointestinal cancer, osteosarcoma, leukemia, glioblastoma, lung cancer, hepatocellular carcinoma, ovarian cancer, pancreatic cancer etc.

Patent granted in India to NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER)

Patent number 373139 has been granted to NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER) that is titled CAN IMPROVED PROCESS FOR THE PREPARATION OF SULFONYLUREAS. The primary independent claim of this patent states a process to produce compound and salts thereof by reacting a compound of the formula with an acyclic carbonate ester compound in the presence of first solvent and at an appropriate temperature to form a mixture and further extracting the mixture obtained, with an organic solvent to separate the extracts of compounds of the formula II. The patent applicant responded to this objection by stating that in the present invention, the carbamate can be prepared by reacting an amine with an acyclic carbonate ester in aqueous or aqueous-organic solvents without using any base. This patent falls under the category of Chemical. Overall, this patent covers a process for the preparation of sulfonylurea compounds of formula I as anti-diabetic agents with high purity and yield and without the use of any hazardous reagents.

Patent granted in India to PFIZER INC

August 7, 2021

Patent number 372466 has been granted to PFIZER INC. that is titled SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS. The primary independent claim of this patent states a compound of formula, or a pharmaceutically acceptable salt thereof. During the patent prosecution, the patent examiner objected to this patent under section 3(d) of the Indian Patents Act. The patent applicant responded to this objection by stating that Section 3(d) does not apply to all pharmaceutical and chemical inventions.

Patent granted in India to TEIJIN PHARMA LIMITED

Patent number 372415 has been granted to TEIJIN PHARMA LIMITED that is titled CRYSTAL OF AZOLE BENZENE DERIVATIVE. The patent applicant responded to this objection by stating that section 3(d) does not apply to the present compounds, as the claimed compound is a novel compound and the claims relate to a crystal form of a novel compound, and therefore the claimed crystal form is a novel form of a novel compound. This patent falls under the category of Chemical. Overall, this patent covers The present invention relates to a crystal of 2-[-4-(2,2-dimethylpropoxy)-3-(1H-1,2,3,4-tetrazol-lyl)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid.

Patent granted in India to HITACHI LTD

Patent number 372440 has been granted to HITACHI LTD. that is titled COMPUTER SYSTEM DATA PROCESSING METHOD AND DATA PROCESSING PROGRAM. The primary independent claim of this patent states a system wherein multiple nodes are coupled via a communication network, further one node from among the multiple nodes becomes a leader node while the other nodes besides the leader node become follower nodes. The patent applicant responded to this objection by stating that the present invention is not a computer program per se and also provides a technical effect which is technically advanced over the known arts. This patent falls under the category of Computer Science. Overall, this patent covers a computer system for synchronously executing multiple tasks on multiple computers.

Patent granted in India to SCHNEIDER ELECTRIC IT CORPORATION

Patent number 372411 has been granted to SCHNEIDER ELECTRIC IT CORPORATION, which is titled DATA CENTER CONTROL. The primary independent claim of this patent states a computer implemented system and method for data center control that identifies parameters of one or more data centers. The patent applicant responded to this objection by stating that the present invention is not a computer program per se and also provides a technical effect which is technically advanced over the known arts. This patent falls under the category of Communication. Overall, this patent covers systems and methods for data center control that identify parameters of one or more data centers.

Patent granted in India to E I DU PONT DE NEMOURS and ARCHER DANIELS MIDLAND COMPANY

July 31, 2021

Patent number 372057 has been granted to E I DU PONT DE NEMOURS and ARCHER DANIELS MIDLAND COMPANY that is titled PROCESSES FOR PRODUCING 2,5-FURANDICARBOXYLIC ACID AND DERIVATIVES THEREOF AND POLYMERS MADE THEREFROM. The primary independent claim of this patent states an integrated process for producing 2,5-furandicarboxylic acid and/or a derivative thereof from a six-carbon sugar-containing feed that is dehydrated in the presence of a bromine source and of a solvent, at an elevated temperature and for a time sufficient to generate an oxidation feed of at least one of 5-hydroxymethylfurfural and/or a derivative or derivatives of 5-hydroxymethylfurfural in the solvent, together with at least one bromine containing species and contacting the oxidation feed with a homogenous metal catalyst based on Co and Mn and with an oxygen source at an elevated temperature for a time sufficient to produce an oxidation product mixture of 2,5-furandicarboxylic acid (FDCA) and/or a derivative thereof, the solvent, and a residual catalyst. The patent applicant responded to this objection by stating that the present invention is novel and is not published in any of the prior arts. This patent falls under the category of Chemical. Overall, this patent covers the process for producing 2,5-furandicarboxylic acid and derivatives thereof and polymers made therefrom.

Patent granted in India to NOVARTIS AG

patent number 372099, has been granted to NOVARTIS AG titled COMPOSITIONS AND METHODS FOR MODULATING FARNESOID X RECEPTORS. The primary independent claim of this patent states a compound according to formula or a pharmaceutical acceptable salt thereof, wherein, R0 is Ring A or C1-6 alkyl; Ring A is aryl; 5-10 membered heteroaryl comprising 1-3 N, O or S heteroatoms; or C3-7 cycloalkyl; and said Ring A is unsubstituted or substituted by 1-2 substituents independently represented by R2 ; Ring B is aryl; 5-10 membered heteroaryl comprising 1-3 N, O or S heteroatoms; or C3-7 cycloalkyl; and said Ring B is unsubstituted or substituted by 1-2 substituents independently represented by R2 ; X is –(CR4R5 )–; Y is –O–, –(CR4R5 )–, or *–O(CR4R5 )–, wherein “*” indicates the point of attachment of Y to the ring containing the Z ring atoms; Z 1 , Z2 , Z3 , and Z4 are each independently –CR3– or –N–; L 1 is *1–(CR4R5 )1-2– wherein “*1 ” indicates the point of attachment of L1 to N; L 2 is *2–(CR4R5 )1-2–, *2–(CR4R5 )-C(O)-NR–, *2–(CR4R5 )2-O–, *2–(CR4R5 )2-NR– or * 2–(CR4R5 )-C(O)-NR-(CR4R5 )–; wherein “*2 ” indicates the point of attachment of L2 to N; L 3 is –C(O)–; each R2 is independently halo, C1-6 alkyl, or halo-substituted C1-6 alkyl; each R3 is independently hydrogen, halo, or C1-6 alkyl; R, R4 and R5 are independently hydrogen or C1-6 alkyl. The patent applicant responded to this objection by stating that the present invention discloses novel tricyclic compounds that are not known at the priority date. Moreover, the compounds of the present invention are structurally different from the compounds disclosed in the cited prior art. This patent falls under the category of Pharmaceuticals. Overall, this patent covers a compounds of Formula wherein, a stereoisomer, enantiomer, a pharmaceutically acceptable salt or an amino acid conjugate thereof; and their pharmaceutical compositions, which are useful as modulators of the activity of Farnesoid X receptors (FXR).

GIP Research & Consultancy Services

Tag: Patent Process in India